Citation Impact

Citing Papers

2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
The Chicago Classification of esophageal motility disorders, v3.0
2014 Standout
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
2013 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification
1999 Standout
Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: A case-control study☆, ☆☆
1999
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Functional Gastroduodenal Disorders
2006 Standout
Gastro‐oesophageal reflux symptoms and health‐related quality of life in the adult general population – the Kalixanda study
2006
Hepatocellular carcinoma
2016 Standout
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
Rapid Urease Tests Lack Sensitivity in Helicobacter Pylori Diagnosis When Peptic Ulcer Disease Presents With Bleeding
2000
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Lansoprazole Treatment of Patients With Chronic Idiopathic Laryngitis: A Placebo-Controlled Trial
2001
Burden of liver diseases in the world
2018 Standout
Systematic Review: Patterns of Reflux-Induced Symptoms and Esophageal Endoscopic Findings in Large-Scale Surveys
2012
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
Capsaicin receptor (TRPV1) and non-erosive reflux disease
2006
Trends in Acute Nonvariceal Upper Gastrointestinal Bleeding in Dialysis Patients
2012 Standout
Failure to respond to physiologic challenge characterizes esophageal motility in erosive gastro-esophageal reflux disease
2011
The Usefulness of Capsulated 13C-Urea Breath Test in Diagnosis of Helicobacter pylori Infection in Patients With Upper Gastrointestinal Bleeding
2003
Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy for the prevention of recurrent bleeding from peptic ulcer
2004
What is the Best Method to Diagnose Helicobacter Infection in Bleeding Peptic Ulcers ? : A Prospective Trial
2001
Systematic review: the effects of conservative and surgical treatment for obesity on gastro‐oesophageal reflux disease
2009
Endoscopic Retreatment Compared with Surgery in Patients with Recurrent Bleeding after Initial Endoscopic Control of Bleeding Ulcers
1999
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Hepatocellular carcinoma
2012 Standout
Rapid urease test is less sensitive than histology in diagnosing Helicobacter pylori infection in patients with non‐variceal upper gastrointestinal bleeding
2000
Gastro-Duodenal Lesions and Helicobacter pylori Infection in Uremic Patients and Renal Transplant Recipients
2007
Has H. pylori Prevalence in Bleeding Peptic Ulcer Been Underestimated? A Meta-Regression
2011
Gastroesophageal Reflux Disease (GERD)
2009
Four-year trends in Helicobacter pylori IgG serology following successful eradication
1998
Meta-DiSc: a software for meta-analysis of test accuracy data
2006 Standout
Biological roles of glycans
2016 Standout
Gastroesophageal Reflux Symptoms and Well-Being in a Random Sample of the General Population of a Swedish Community
2005
Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: Evidence from clinical and pharmacokinetic data
2005
Epidemiology of gastro-oesophageal reflux disease: a systematic review
2005 Standout
Sleep dysfunction in patients with gastro‐oesophageal reflux disease: prevalence and response to GERD therapy, a pilot study
2004
Eradication ofH. pyloriwith Pantoprazole, Clarithromycin, and Metronidazole in Duodenal Ulcer Patients: A Head‐to‐Head Comparison Between Two Regimens of Different Duration
2000
Control of Gastric Acid Secretion in Health and Disease
2008
Portal hypertensive bleeding in cirrhosis
2016 Standout
Reassessment of the Diagnostic Value of Histology in Patients with GERD, Using Multiple Biopsy Sites and an Appropriate Control Group
2005
Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases
2008
Body-Mass Index and Symptoms of Gastroesophageal Reflux in Women
2006
Complications of gastro-oesophageal reflux disease
2013
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Up‐regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course
2006
H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer
2003
13C‐urea Breath Test during Hospitalization for the Diagnosis of Helicobacter pylori Infection in Peptic Ulcer Bleeding
2007
Helicobacter pylori and Gastroesophageal Reflux Disease: A Case–Control Study
2008
Accuracy of GastroPanel for the diagnosis of atrophic gastritis
2014
Natural history of gastro‐oesophageal reflux disease diagnosed in general practice
2004
High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report
2005
Prevalence, clinical spectrum and atypical symptoms of gastro‐oesophageal reflux in Argentina: a nationwide population‐based study
2005
Management of Patients With Ulcer Bleeding
2012 Standout
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006 Standout
Biliary Tract Cancers
1999
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
2010 Standout
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
The Impact of Helicobacter pylori Eradication on Peptic Ulcer Healing
1998
Natural history of bleeding peptic ulcers with a tightly adherent blood clot: a prospective observation
1996
Effect of Esomeprazole on Nighttime Heartburn and Sleep Quality in Patients with GERD: A Randomized, Placebo-Controlled Trial
2005
Symptomatic gastro‐oesophageal reflux, arousals and sleep quality in patients undergoing polysomnography for possible obstructive sleep apnoea
2004
Treatment of Helicobacter pylori Infection: A Review of the World Literature
1996
The long‐term management of patients with bleeding duodenal ulcers
1997
Comparison of invasive and noninvasive tests for detecting Helicobacter pylori infection in bleeding peptic ulcers
1999
The cost‐effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial
2002
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Gastroesophageal Reflux Disease and Asthma
2005
The Morbidity and Mortality Associated With Overweight and Obesity in Adulthood
2009
Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients
2002 Standout
Symptomatic benefit 1-3 years after h. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease
2000
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Managing Gastroesophageal Reflux Disease in Primary Care: The Patient Perspective
2005
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
Accuracy of Helicobacter pylori Diagnostic Tests in Patients with Bleeding Peptic Ulcer: A Systematic Review and Meta-analysis
2006
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Abdominal Symptoms: Do They Predict Gallstones?: A Systematic Review
2000
Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer
2004
Meta-Analysis: Obesity and the Risk for Gastroesophageal Reflux Disease and Its Complications
2005
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
2015 Standout
Effect of Pantoprazole on the Course of Reflux-Associated Laryngitis: a Placebo-Controlled Double-Blind Crossover Study
2003
Hyaluronan as an Immune Regulator in Human Diseases
2011
Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding
2003
CanadianHelicobacter pyloriConsensus Conference
1998
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Pernicious Anaemia, Intragastric Bacterial Overgrowth, and Possible Consequences
1984
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
2001 Standout
Pharmacologic and Therapeutic Considerations in Hypertension Therapy With Calcium Channel Blockers: Focus on Verapamil
2007
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Surgery for weight loss in adults
2014 Standout
The impact of Helicobacter pylori eradication on peptic ulcer healing
1998
Epidemiology of gastric cancer
2006 Standout
Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage
2001
Treatment options for Helicobacter pylori infection when proton pump inhibitor‐based triple therapy fails in clinical practice
1999
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model
2003
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel

Works of D Jaspersen being referenced

Cost‐of‐disease analysis in patients with gastro‐oesophageal reflux disease and Barrett's mucosa
2006
What Parameters Are Relevant for the Histological Diagnosis of Gastroesophageal Reflux Disease without Barrett’s Mucosa?
2004
Diagnosis and treatment control of bleeding colorectal angiodysplasias by endoscopic Doppler sonography: A preliminary study
1994
Helicobacter pylori Eradication: The Best Long-Term Prophylaxis for Ulcer Bleeding Recurrence?
1995
Quality of life in relation to symptoms in patients with gastro‐oesophageal reflux disease — an analysis based on the ProGERD initiative
2003
Correlation of serum pepsinogens and gastrin‐17 with atrophic gastritis in gastroesophageal reflux patients: A matched‐pairs study
2010
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study
2004
Long‐term treatment of patients with gastro‐oesophageal reflux disease in routine care – results from the ProGERD study
2007
Prevalence of extra‐oesophageal manifestations in gastro‐oesophageal reflux disease: an analysis based on the ProGERD Study
2003
OMEPRAZOLE AND COMPLICATED GASTRO‐OESOPHAGEAL REFLUX DISEASE
1996
Risk Factors for Erosive Esophagitis: A Multivariate Analysis Based on the ProGERD Study Initiative
2004
Significantly lower prevalence ofHelicobacter pylori in uremic patients than in patients with normal renal function
1995
Effect of omeprazole on the course of associated esophagitis and laryngitis
1996
Prospective Follow-Up Data from the ProGERD Study Suggest that GERD Is Not a Categorial Disease
2006
Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: an entity of concern in the ProGERD study
2012
Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage
1995
[Fibronectin in human bile--a new parameter for diagnosis of malignant bile duct processes?--A pilot study].
1994
Improvement of prognostic power of the Child–Pugh classification of liver cirrhosis by hyaluronan
2003
Medication-induced oesophageal disorders
2003
Eradication of Helicobacter pylori reduces the rate of rebleeding in complicated ulcer disease
1995
[(Incidence of gallstone disease in autopsy material and outpatients from West Germany) ].
1982
Rankless by CCL
2026